Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2022 | Improving diversity in clinical trial participation

Clara Hwang • 4 Jun 2022
ASCO 2022
General

Clara Hwang, MD, Henry Ford Health System, Detroit, MI, reflects on the importance of improving diversity in clinical trial participation highlighting barriers to enrollment as well as financial burdens faced by patients. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.

More from Clara Hwang

0:36
Addressing healthcare delivery
Clara Hwang • 4 Jun 2022
1:34
Biomarker-directed therapy in black and white men with mCRPC
Clara Hwang • 4 Jun 2022

Related Videos

0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
3:10
PALOMA: subcutaneous amivantamab in advanced solid tumors
Natasha Leighl • 17 Apr 2024
The content of VJOncology is intended for healthcare professionals